This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gramantieri, L. Articles by Negrini, M. Search for Related Content PubMed PubMed Citation Articles by Gramantieri, L. Articles by Negrini, M.

Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

¹ Dipartimento di Medicina Interna e Gastroenterologia e Centro di Ricerca Biomedica Applicata, Università di Bologna, Bologna, Italy; ² Dipartimento di Medicina Sperimentale e Diagnostica e Centro Interdipartimentale per la Ricerca sul Cancro, Università di Ferrara, Ferrara, Italy; ³ Istituto Oncologico Veneto, Rovigo, Italy; and ⁴ Comprehensive Cancer Center, Ohio State University, Columbus, Ohio

Requests for reprints: Massimo Negrini, Dipartimento di Medicina Sperimentale e Diagnostica, Università di Ferrara, via Luigi Borsari 46, 44100 Ferrara, Italy. Phone: 39-0532-291399/291400; Fax: 39-0532-247618; E-mail: ngm{at}unife.it.

We investigated the role of microRNAs (miRNAs) in the pathogenesis of human hepatocellular carcinoma (HCC). A genome-wide miRNA microarray was used to identify differentially expressed miRNAs in HCCs arisen on cirrhotic livers. Thirty-five miRNAs were identified. Several of these miRNAs were previously found deregulated in other human cancers, such as members of the let-7 family, mir-221, and mir-145. In addition, the hepato-specific miR-122a was found down-regulated in 70% of HCCs and in all HCC-derived cell lines. Microarray data for let-7a, mir-221, and mir-122a were validated by Northern blot and real-time PCR analysis. Understanding the contribution of deregulated miRNAs to cancer requires the identification of gene targets. Here, we show that miR-122a can modulate cyclin G1 expression in HCC-derived cell lines and an inverse correlation between miR-122a and cyclin G1 expression exists in primary liver carcinomas. These results indicate that cyclin G1 is a target of miR-122a and expand our knowledge of the molecular alterations involved in HCC pathogenesis and of the role of miRNAs in human cancer. [Cancer Res 2007;67(13):6092–9]

This article has been cited by other articles:

				S. Sakamoto, K. Aoki, T. Higuchi, H. Todaka, K. Morisawa, N. Tamaki, E. Hatano, A. Fukushima, T. Taniguchi, and Y. Agata The NF90-NF45 Complex Functions as a Negative Regulator in the MicroRNA Processing Pathway Mol. Cell. Biol., July 1, 2009; 29(13): 3754 - 3769. [Abstract] [Full Text] [PDF]

				T Asselah, I Bieche, A Sabbagh, P Bedossa, R Moreau, D Valla, M Vidaud, and P Marcellin Gene expression and hepatitis C virus infection Gut, June 1, 2009; 58(6): 846 - 858. [Abstract] [Full Text] [PDF]

				N. S. Wickramasinghe, T. T. Manavalan, S. M. Dougherty, K. A. Riggs, Y. Li, and C. M. Klinge Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Nucleic Acids Res., May 1, 2009; 37(8): 2584 - 2595. [Abstract] [Full Text] [PDF]

				R. Visone and C. M. Croce MiRNAs and Cancer Am. J. Pathol., April 1, 2009; 174(4): 1131 - 1138. [Abstract] [Full Text] [PDF]

				M. Z. Carletti and L. K. Christenson MicroRNA in the ovary and female reproductive tract J Anim Sci, April 1, 2009; 87(14_suppl): E29 - E38. [Abstract] [Full Text] [PDF]

				H. Li, K. Okamoto, M. J. Peart, and C. Prives Lysine-Independent Turnover of Cyclin G1 Can Be Stabilized by B'{alpha} Subunits of Protein Phosphatase 2A Mol. Cell. Biol., February 1, 2009; 29(3): 919 - 928. [Abstract] [Full Text] [PDF]

				H. Su, J.-R. Yang, T. Xu, J. Huang, L. Xu, Y. Yuan, and S.-M. Zhuang MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity Cancer Res., February 1, 2009; 69(3): 1135 - 1142. [Abstract] [Full Text] [PDF]

				Y. Pei, T. Zhang, V. Renault, and X. Zhang An overview of hepatocellular carcinoma study by omics-based methods Acta Biochim Biophys Sin, January 1, 2009; 41(1): 1 - 15. [Abstract] [Full Text] [PDF]

				U Siebolts, H Varnholt, U Drebber, H-P Dienes, C Wickenhauser, and M Odenthal Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR J. Clin. Pathol., January 1, 2009; 62(1): 84 - 88. [Abstract] [Full Text] [PDF]

				L.-X. Yan, X.-F. Huang, Q. Shao, M.-Y. Huang, L. Deng, Q.-L. Wu, Y.-X. Zeng, and J.-Y. Shao MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis RNA, November 1, 2008; 14(11): 2348 - 2360. [Abstract] [Full Text] [PDF]

				T. Daikoku, Y. Hirota, S. Tranguch, A. R. Joshi, F. J. DeMayo, J. P. Lydon, L. H. Ellenson, and S. K. Dey Conditional Loss of Uterine Pten Unfailingly and Rapidly Induces Endometrial Cancer in Mice Cancer Res., July 15, 2008; 68(14): 5619 - 5627. [Abstract] [Full Text] [PDF]

				H. Bruchova, M. Merkerova, and J. T. Prchal Aberrant expression of microRNA in polycythemia vera Haematologica, July 1, 2008; 93(7): 1009 - 1016. [Abstract] [Full Text] [PDF]

				E. J. Lee, M. Baek, Y. Gusev, D. J. Brackett, G. J. Nuovo, and T. D. Schmittgen Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors RNA, January 1, 2008; 14(1): 35 - 42. [Abstract] [Full Text] [PDF]